Maria Uhlig

Medical Assistant
National Center for Tumor Diseases/ University Cancer Center Dresden

[Maria Uhlig @MariaUhlig4]

@BalaianEn I’m sure you’ll meet just as many inspiring people and hear equally fascinating talks – have a great time!

[The Lancet @TheLancet]

VEXAS syndrome is a newly discovered multisystemic disease affecting most organs.

A new Review provides a comprehensive overview of VEXAS syndrome, including the disease's discovery, diagnosis, and treatment: https://t.co/pZSkkGPbGJ

[katharina goetze @GoetzeKatharina]

Education is key to patient empowerment and involvement. Yesterday, we hosted the first #VEXAS patient café at the University hospital in Dresden - bringing together patients and their partners from across Germany to learn, connect and engage!

[Maria Uhlig @MariaUhlig4]

#Patiententag #ITP #SAA #PNH #Hämatologie #SelteneErkrankungen #Dresden #Gesundheit #Selbsthilfe #UniklinikumDresden

[Maria Uhlig @MariaUhlig4]

Seltene Erkrankungen verdienen Aufmerksamkeit und Austausch:
Wir laden Patient:innen, Angehörige und Interessierte herzlich zum 2. Patiententag für ITP, SAA und PNH ein.

📅 15. November 2025 🕘 09:00 – 12:00 Uhr
📍 MTZ, Universitätsklinikum Dresden

[Maria Uhlig @MariaUhlig4]

Erfahren Sie mehr über seltene Bluterkrankungen, neue Therapien und Unterstützungsmöglichkeiten. Mit Fachvorträgen, Patient:innenberichten und Fragerunden.

✅ Kostenfreie Teilnahme
✍️ Anmeldung bis 10.11.2025:
👉 https://t.co/Zy274bFWnC
📧 [email protected]

[Maria Uhlig @MariaUhlig4]

🙏 Danke an unsere Partner: Bristol Myers Squibb-Stiftung, SOBI, GSK, Otsuka & Carus Management GmbH.

#VEXAS #SelteneErkrankungen #Patientencafé #Dresden

[Maria Uhlig @MariaUhlig4]

VEXAS-Syndrom – selten, aber nicht allein!
Wir laden Betroffene & Angehörige herzlich zum 1. Patientencafé des VEXAS-Registers ein!
🤝 Austausch, 🗣️ Fragen stellen, 💡 Verständnis finden.

🗓️ 6.11.2025 | 15:30 – 18:00
📍 Uniklinikum Dresden
🔗 https://t.co/2SyjDBopS1

[Katja Sockel @KatjaSockel]

Thanks to @BloodJournal for highlighting our study on #pregnancies after #alloHCT and to @MaryEapen for her very insightful commentary on this topic!

https://t.co/dvP9V18Ku8

#pregnancy #alloHCT @drst_data

[Ärzte Zeitung @aerztezeitung]

Zehn #Hausarztpraxen erproben in Baden-Württemberg auf Basis des „#HÄPPI“-Konzepts die Versorgung der Zukunft. Was treibt Ärztinnen und Ärzte sowie das Praxisteam an? Die Ärzte Zeitung hat in zwei Pilotpraxen nachgefragt. #BaWü

https://t.co/JaHYYo3cmp

[Munich Leukemia Laboratory @leukaemielabor]

📄This research perspective thoroughly examines the impact of #UBA1 loss of function & recent advancements in #VEXAS research, focusing on inflammation, cytopenias, clonality, and oncogenic potential; highlighting in particular M41 versus non-M41 mutations https://t.co/wJRmA4AMtC

[The Lancet Haematology @TheLancetHaem]

"All patients eligible for fertility preservation should be appropriately counselled... however, at least for younger women undergoing HSCT, there is hope that pregnancy is possible following this life-saving procedure" #bmtsm

NEW editorial https://t.co/w48YEDhuQq

[Maria Uhlig @MariaUhlig4]

Real hope for motherhood after stem cell transplantation! A study of @KatjaSockel shows that safe, successful pregnancy may be possible following Allo-HCT.
#Cancer #hematology #alloHCT #leusm #leukemia #fertility #pregnancy

[Katja Sockel @KatjaSockel]

👇Excited to share that our study “Hope for Motherhood: Pregnancy After Allogeneic Hematopoietic Cell Transplantation“ is out now @BloodJournal !

https://t.co/awvjP3qg4O

@FertiPROTEKT @CancerSurvSM

[Katja Sockel @KatjaSockel]

Thank you @ASCOPost for highlighting our study 🤩
@BloodJournal

[ASH @ASH_hematology]

Despite treatment-related fertility challenges, female patients can become pregnant and give birth to healthy children after undergoing allogeneic hematopoietic cell transplantation.

Read the new study: https://t.co/KvEPrWA2kb @KatjaSockel @BloodJournal @Medizin_TUD

[Helena Jambor is gone elsewhere. @helenajambor]

🚨New paper 🚨
#Patients may feel overwhelmed/anxious when learning about a cancer diagnosis. This lowers comprehension of health information & may cause non-adherence to therapies. To bridge this health literacy gap we used visual aids to communicating #CancerTreatment paths.
1/

[Jakob Nikolas Kather @jnkath]

Happy to share our latest paper by @ElNahhasOSM et al., which was just published in @NatureComms! This work presents a new method which improves the prediction of biomarkers from routine pathology slides. https://t.co/NPUhaf4tpn @tudresden_de @katherlab @Medizin_TUD

[Stiftung Immunonkologie @Stiftung_IO]

Für die nächsten 2 Jahre fördern wir ein #Forschungsprojekt der Uniklinik #Dresden und dem Klinikum rechts der Isar, TU #München: Ein multizentrisches, nationales #Register mit begleitender Biomaterialsammlung zum #VEXAS-Syndrom

[OncoDaily @oncodaily]

Thrilled to share that 2 of our Vexas patients achieved complete molecular remission with HMA therapy - @KatjaSockel
https://t.co/t45ozMj5dR

#Cancer #MolecularRemission #HMATherapy #OncoDaily #Oncology #CancerCare

[Katja Sockel @KatjaSockel]

Thrilled to share that 2 of our #Vexas patients achieved complete molecular remission with HMA therapy, enabling treatment de-escalation. 👇@SpringerNature @VEXASfoundation

https://t.co/LzqC6npdRa